Clinuvel Pharmaceuticals Ltd. carries a market capitalization of 304.08M, placing it among publicly traded companies globally.
| Market Cap | 304.08M |
| Enterprise Value | N/A |
Clinuvel Pharmaceuticals Ltd.'s stock has declined approximately -14.46809% over the past 52 weeks. The 50-day moving average sits at 6.49, while the 200-day moving average is 7.11.
| Beta (5Y) | N/A |
| 52-Week Price Change | -14.46809% |
| 50-Day Moving Average | 6.49 |
| 200-Day Moving Average | 7.11 |
| Average Volume (20 Days) | N/A |